US Stock MarketDetailed Quotes

UroGen Pharma Ltd (URGN)

Watchlist

29.720
+0.220+0.75%

Close Jun 12 16:00 ET

29.720
0.0000.00%

Post 20:01 ET

1.45BMarket Cap-10.85P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

UroGen Pharma Ltd (URGN) Balance Sheet

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Assets

Current assets

Cash, cash equivalents and short term investments

-28.39%140.27M

-49.11%120.46M

-49.10%127.03M

-34.89%156.95M

19.41%195.89M

72.80%236.69M

69.30%249.58M

409.67%241.08M

-Cash and cash equivalents

5.70%109.97M

-35.61%110.75M

-27.92%90.04M

-57.77%92.9M

-20.85%104.03M

81.04%171.99M

4.70%124.92M

992.92%219.97M

-Short-term investments

-67.01%30.31M

-84.99%9.71M

-70.32%36.99M

203.47%64.05M

181.72%91.86M

54.17%64.7M

343.41%124.66M

-22.33%21.11M

Receivables

182.17%55.41M

62.95%33.08M

-13.59%19.7M

12.83%19.65M

38.71%19.64M

31.46%20.3M

77.49%22.8M

12.32%17.42M

-Accounts receivable

182.17%55.41M

62.95%33.08M

-13.59%19.7M

12.83%19.65M

38.71%19.64M

31.46%20.3M

77.49%22.8M

12.32%17.42M

Inventory

175.64%20.92M

78.43%16.46M

9.84%8.34M

-4.22%7.13M

4.79%7.59M

62.65%9.23M

51.82%7.59M

49.20%7.44M

Restricted cash

23.33%1.33M

25.46%1.35M

25.54%1.35M

31.15%1.08M

30.74%1.08M

31.06%1.08M

31.33%1.07M

1.10%825K

Other current assets

50.43%19.53M

65.88%14.67M

-13.74%12.12M

-1.25%12.06M

23.75%12.98M

-13.97%8.85M

-12.38%14.05M

-4.05%12.21M

Total current assets

0.12%237.46M

-32.63%186.02M

-42.88%168.55M

-29.43%196.87M

20.54%237.18M

63.21%276.14M

62.03%295.1M

242.99%278.97M

Non current assets

Net PPE

59.03%8.56M

139.98%9.09M

453.25%9.18M

240.93%6.24M

167.79%5.38M

60.55%3.79M

-39.15%1.66M

-39.34%1.83M

-Gross PPE

35.81%13.22M

69.52%13.68M

133.22%13.7M

78.61%10.67M

59.98%9.73M

27.85%8.07M

-9.51%5.87M

-9.36%5.98M

-Accumulated depreciation

-7.10%-4.66M

-7.15%-4.59M

-7.12%-4.51M

-6.95%-4.43M

-6.82%-4.35M

-8.32%-4.28M

-11.99%-4.21M

-15.94%-4.15M

Investments and advances

----

--0

-91.81%380K

2,181.77%4.63M

838.46%4.51M

11.55%5.02M

-28.68%4.64M

-97.45%203K

Other non current assets

1,302.19%7.67M

597.78%5.34M

1,172.66%6.94M

15.33%978K

-58.69%547K

-66.20%765K

-76.04%545K

-72.11%848K

Total non current assets

55.41%16.23M

50.70%14.43M

141.02%16.5M

311.28%11.85M

173.75%10.44M

4.94%9.58M

-40.52%6.85M

-79.46%2.88M

Total assets

2.45%253.69M

-29.84%200.46M

-38.71%185.05M

-25.95%208.72M

23.45%247.62M

60.23%285.71M

55.94%301.94M

195.56%281.85M

Liabilities

Current liabilities

Payables

18.14%17.21M

11.03%12.14M

85.01%10.28M

63.09%13.56M

132.74%14.57M

67.81%10.93M

37.49%5.56M

78.51%8.32M

-accounts payable

18.14%17.21M

11.03%12.14M

85.01%10.28M

63.09%13.56M

132.74%14.57M

67.81%10.93M

37.49%5.56M

78.51%8.32M

Current accrued expenses

15.12%18.14M

-5.58%15.58M

12.49%15.89M

12.70%17.4M

32.41%15.76M

64.60%16.5M

40.70%14.13M

31.45%15.44M

Other current liabilities

15.73%5.45M

-34.76%5.19M

21.70%4.96M

36.46%4.94M

47.36%4.71M

105.91%7.95M

14.64%4.07M

-0.58%3.62M

Current liabilities

20.56%50.64M

1.02%46.42M

28.84%42.24M

38.94%47.55M

59.45%42M

47.22%45.95M

27.14%32.79M

27.86%34.22M

Non current liabilities

Long term debt and capital lease obligation

56.21%195.18M

4.01%128.33M

5.27%128.35M

28.18%125.92M

27.20%124.95M

24.14%123.39M

22.48%121.92M

-1.27%98.24M

-Long term debt

55.22%189.53M

0.39%122.21M

0.33%122.11M

25.25%122.51M

25.12%122.11M

23.52%121.73M

23.54%121.71M

-0.49%97.81M

-Long term capital lease obligation

98.77%5.65M

270.36%6.12M

2,843.87%6.24M

703.06%3.41M

346.00%2.84M

95.85%1.65M

-79.34%212K

-64.85%425K

Derivative product liabilities

3.97%128.23M

4.85%127.28M

6.36%126.07M

7.73%124.83M

9.20%123.34M

10.63%121.39M

10.49%118.53M

10.88%115.88M

Total non current liabilities

29.84%327.31M

4.40%259.51M

5.98%258.21M

17.13%254.55M

17.59%252.08M

17.08%248.57M

16.11%243.64M

4.97%217.31M

Total liabilities

28.52%377.94M

3.88%305.93M

8.69%300.45M

20.10%302.09M

22.17%294.08M

20.94%294.51M

17.32%276.43M

7.59%251.54M

Shareholders'equity

Share capital

6.35%134K

15.65%133K

11.30%128K

12.50%126K

27.27%126K

29.21%115K

36.90%115K

75.00%112K

-common stock

6.35%134K

15.65%133K

11.30%128K

12.50%126K

27.27%126K

29.21%115K

36.90%115K

75.00%112K

Retained earnings

-15.67%-983.29M

-19.04%-959.72M

-21.42%-933.35M

-20.80%-900.01M

-19.45%-850.07M

-18.68%-806.22M

-17.66%-768.71M

-17.99%-745.04M

Paid-in capital

6.90%858.9M

7.13%854.09M

3.01%817.79M

4.03%806.5M

19.66%803.47M

29.84%797.25M

29.85%793.87M

57.22%775.27M

Gains losses not affecting retained earnings

-42.86%8K

-66.07%19K

-90.25%23K

119.35%6K

137.84%14K

366.67%56K

276.12%236K

79.87%-31K

Total stockholders'equity

-167.45%-124.25M

-1,098.16%-105.47M

-552.31%-115.41M

-408.03%-93.38M

-15.76%-46.46M

86.50%-8.8M

160.76%25.52M

121.90%30.31M

Total equity

-167.45%-124.25M

-1,098.16%-105.47M

-552.31%-115.41M

-408.03%-93.38M

-15.76%-46.46M

86.50%-8.8M

160.76%25.52M

121.90%30.31M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments	-28.39%140.27M	-49.11%120.46M	-49.11%120.46M	-49.10%127.03M	-34.89%156.95M	19.41%195.89M	72.80%236.69M	72.80%236.69M	69.30%249.58M	409.67%241.08M
-Cash and cash equivalents	5.70%109.97M	-35.61%110.75M	-35.61%110.75M	-27.92%90.04M	-57.77%92.9M	-20.85%104.03M	81.04%171.99M	81.04%171.99M	4.70%124.92M	992.92%219.97M
-Short-term investments	-67.01%30.31M	-84.99%9.71M	-84.99%9.71M	-70.32%36.99M	203.47%64.05M	181.72%91.86M	54.17%64.7M	54.17%64.7M	343.41%124.66M	-22.33%21.11M
Receivables	182.17%55.41M	62.95%33.08M	62.95%33.08M	-13.59%19.7M	12.83%19.65M	38.71%19.64M	31.46%20.3M	31.46%20.3M	77.49%22.8M	12.32%17.42M
-Accounts receivable	182.17%55.41M	62.95%33.08M	62.95%33.08M	-13.59%19.7M	12.83%19.65M	38.71%19.64M	31.46%20.3M	31.46%20.3M	77.49%22.8M	12.32%17.42M
Inventory	175.64%20.92M	78.43%16.46M	78.43%16.46M	9.84%8.34M	-4.22%7.13M	4.79%7.59M	62.65%9.23M	62.65%9.23M	51.82%7.59M	49.20%7.44M
Restricted cash	23.33%1.33M	25.46%1.35M	25.46%1.35M	25.54%1.35M	31.15%1.08M	30.74%1.08M	31.06%1.08M	31.06%1.08M	31.33%1.07M	1.10%825K
Other current assets	50.43%19.53M	65.88%14.67M	65.88%14.67M	-13.74%12.12M	-1.25%12.06M	23.75%12.98M	-13.97%8.85M	-13.97%8.85M	-12.38%14.05M	-4.05%12.21M
Total current assets	0.12%237.46M	-32.63%186.02M	-32.63%186.02M	-42.88%168.55M	-29.43%196.87M	20.54%237.18M	63.21%276.14M	63.21%276.14M	62.03%295.1M	242.99%278.97M
Non current assets
Net PPE	59.03%8.56M	139.98%9.09M	139.98%9.09M	453.25%9.18M	240.93%6.24M	167.79%5.38M	60.55%3.79M	60.55%3.79M	-39.15%1.66M	-39.34%1.83M
-Gross PPE	35.81%13.22M	69.52%13.68M	69.52%13.68M	133.22%13.7M	78.61%10.67M	59.98%9.73M	27.85%8.07M	27.85%8.07M	-9.51%5.87M	-9.36%5.98M
-Accumulated depreciation	-7.10%-4.66M	-7.15%-4.59M	-7.15%-4.59M	-7.12%-4.51M	-6.95%-4.43M	-6.82%-4.35M	-8.32%-4.28M	-8.32%-4.28M	-11.99%-4.21M	-15.94%-4.15M
Investments and advances	----	--0	--0	-91.81%380K	2,181.77%4.63M	838.46%4.51M	11.55%5.02M	11.55%5.02M	-28.68%4.64M	-97.45%203K
Other non current assets	1,302.19%7.67M	597.78%5.34M	597.78%5.34M	1,172.66%6.94M	15.33%978K	-58.69%547K	-66.20%765K	-66.20%765K	-76.04%545K	-72.11%848K
Total non current assets	55.41%16.23M	50.70%14.43M	50.70%14.43M	141.02%16.5M	311.28%11.85M	173.75%10.44M	4.94%9.58M	4.94%9.58M	-40.52%6.85M	-79.46%2.88M
Total assets	2.45%253.69M	-29.84%200.46M	-29.84%200.46M	-38.71%185.05M	-25.95%208.72M	23.45%247.62M	60.23%285.71M	60.23%285.71M	55.94%301.94M	195.56%281.85M
Liabilities
Current liabilities
Payables	18.14%17.21M	11.03%12.14M	11.03%12.14M	85.01%10.28M	63.09%13.56M	132.74%14.57M	67.81%10.93M	67.81%10.93M	37.49%5.56M	78.51%8.32M
-accounts payable	18.14%17.21M	11.03%12.14M	11.03%12.14M	85.01%10.28M	63.09%13.56M	132.74%14.57M	67.81%10.93M	67.81%10.93M	37.49%5.56M	78.51%8.32M
Current accrued expenses	15.12%18.14M	-5.58%15.58M	-5.58%15.58M	12.49%15.89M	12.70%17.4M	32.41%15.76M	64.60%16.5M	64.60%16.5M	40.70%14.13M	31.45%15.44M
Other current liabilities	15.73%5.45M	-34.76%5.19M	-34.76%5.19M	21.70%4.96M	36.46%4.94M	47.36%4.71M	105.91%7.95M	105.91%7.95M	14.64%4.07M	-0.58%3.62M
Current liabilities	20.56%50.64M	1.02%46.42M	1.02%46.42M	28.84%42.24M	38.94%47.55M	59.45%42M	47.22%45.95M	47.22%45.95M	27.14%32.79M	27.86%34.22M
Non current liabilities
Long term debt and capital lease obligation	56.21%195.18M	4.01%128.33M	4.01%128.33M	5.27%128.35M	28.18%125.92M	27.20%124.95M	24.14%123.39M	24.14%123.39M	22.48%121.92M	-1.27%98.24M
-Long term debt	55.22%189.53M	0.39%122.21M	0.39%122.21M	0.33%122.11M	25.25%122.51M	25.12%122.11M	23.52%121.73M	23.52%121.73M	23.54%121.71M	-0.49%97.81M
-Long term capital lease obligation	98.77%5.65M	270.36%6.12M	270.36%6.12M	2,843.87%6.24M	703.06%3.41M	346.00%2.84M	95.85%1.65M	95.85%1.65M	-79.34%212K	-64.85%425K
Derivative product liabilities	3.97%128.23M	4.85%127.28M	4.85%127.28M	6.36%126.07M	7.73%124.83M	9.20%123.34M	10.63%121.39M	10.63%121.39M	10.49%118.53M	10.88%115.88M
Total non current liabilities	29.84%327.31M	4.40%259.51M	4.40%259.51M	5.98%258.21M	17.13%254.55M	17.59%252.08M	17.08%248.57M	17.08%248.57M	16.11%243.64M	4.97%217.31M
Total liabilities	28.52%377.94M	3.88%305.93M	3.88%305.93M	8.69%300.45M	20.10%302.09M	22.17%294.08M	20.94%294.51M	20.94%294.51M	17.32%276.43M	7.59%251.54M
Shareholders'equity
Share capital	6.35%134K	15.65%133K	15.65%133K	11.30%128K	12.50%126K	27.27%126K	29.21%115K	29.21%115K	36.90%115K	75.00%112K
-common stock	6.35%134K	15.65%133K	15.65%133K	11.30%128K	12.50%126K	27.27%126K	29.21%115K	29.21%115K	36.90%115K	75.00%112K
Retained earnings	-15.67%-983.29M	-19.04%-959.72M	-19.04%-959.72M	-21.42%-933.35M	-20.80%-900.01M	-19.45%-850.07M	-18.68%-806.22M	-18.68%-806.22M	-17.66%-768.71M	-17.99%-745.04M
Paid-in capital	6.90%858.9M	7.13%854.09M	7.13%854.09M	3.01%817.79M	4.03%806.5M	19.66%803.47M	29.84%797.25M	29.84%797.25M	29.85%793.87M	57.22%775.27M
Gains losses not affecting retained earnings	-42.86%8K	-66.07%19K	-66.07%19K	-90.25%23K	119.35%6K	137.84%14K	366.67%56K	366.67%56K	276.12%236K	79.87%-31K
Total stockholders'equity	-167.45%-124.25M	-1,098.16%-105.47M	-1,098.16%-105.47M	-552.31%-115.41M	-408.03%-93.38M	-15.76%-46.46M	86.50%-8.8M	86.50%-8.8M	160.76%25.52M	121.90%30.31M
Total equity	-167.45%-124.25M	-1,098.16%-105.47M	-1,098.16%-105.47M	-552.31%-115.41M	-408.03%-93.38M	-15.76%-46.46M	86.50%-8.8M	86.50%-8.8M	160.76%25.52M	121.90%30.31M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

The U.S.-Iran negotiations have entered a critical window! According to Bloomberg, both sides are close to signing a memorandum of understan Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm